Literature DB >> 24030425

Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart.

Masashi Kawamura1, Shigeru Miyagawa, Satsuki Fukushima, Atsuhiro Saito, Kenji Miki, Emiko Ito, Nagako Sougawa, Takuji Kawamura, Takashi Daimon, Tatsuya Shimizu, Teruo Okano, Koichi Toda, Yoshiki Sawa.   

Abstract

BACKGROUND: Transplantation of cardiomyocytes that are derived from human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) shows promise in generating new functional myocardium in situ, whereas the survival and functionality of the transplanted cells are critical in considering this therapeutic impact. Cell-sheet method has been used to transplant many functional cells; however, potential ischemia might limit cell survival. The omentum, which is known to have rich vasculature, is expected to be a source of blood supply. We hypothesized that transplantation of hiPS-CM cell sheets combined with an omentum flap may deliver a large number of functional hiPS-CMs with enhanced blood supply. METHODS AND
RESULTS: Retrovirally established human iPS cells were treated with Wnt signaling molecules to induce cardiomyogenic differentiation, followed by superparamagnetic iron oxide labeling. Cell sheets were created from the magnetically labeled hiPS-CMs using temperature-responsive dishes and transplanted to porcine hearts with or without the omentum flap (n=8 each). Two months after transplantation, the survival of superparamagnetic iron oxide-labeled hiPS-CMs, assessed by MRI, was significantly greater in mini-pigs with the omentum than in those without it; histologically, vascular density in the transplanted area was significantly greater in mini-pigs with the omentum than in those without it. The transplanted tissues contained abundant cardiac troponin T-positive cells surrounded by vascular-rich structures.
CONCLUSIONS: The omentum flap enhanced the survival of hiPS-CMs after transplantation via increased angiogenesis, suggesting that this strategy is useful in clinical settings. The combination of hiPS-CMs and the omentum flap may be a promising technique for the development of tissue-engineered vascular-rich new myocardium in vivo.

Entities:  

Keywords:  cell transplantation; induced pluripotent stem cells; regeneration

Mesh:

Year:  2013        PMID: 24030425     DOI: 10.1161/CIRCULATIONAHA.112.000366

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  80 in total

1.  Application of the cell sheet technique in tissue engineering.

Authors:  Guangnan Chen; Yiying Qi; Lie Niu; Tuoyu DI; Jinwei Zhong; Tingting Fang; Weiqi Yan
Journal:  Biomed Rep       Date:  2015-09-29

Review 2.  Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases.

Authors:  Johanna Erbani; Daniel Aberdam; Jerome Larghero; Valérie Vanneaux
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

3.  Isoproterenol directs hair follicle-associated pluripotent (HAP) stem cells to differentiate in vitro to cardiac muscle cells which can be induced to form beating heart-muscle tissue sheets.

Authors:  Aiko Yamazaki; Masateru Yashiro; Sumiyuki Mii; Ryoichi Aki; Yuko Hamada; Nobuko Arakawa; Katsumasa Kawahara; Robert M Hoffman; Yasuyuki Amoh
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 4.  Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Taruna Anand; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

5.  Cell-sheet therapy with omentopexy promotes arteriogenesis and improves coronary circulation physiology in failing heart.

Authors:  Satoshi Kainuma; Shigeru Miyagawa; Satsuki Fukushima; James Pearson; Yi Ching Chen; Atsuhiro Saito; Akima Harada; Motoko Shiozaki; Hiroko Iseoka; Tadashi Watabe; Hiroshi Watabe; Genki Horitsugi; Mana Ishibashi; Hayato Ikeda; Hirotsugu Tsuchimochi; Takashi Sonobe; Yutaka Fujii; Hisamichi Naito; Keiji Umetani; Tatsuya Shimizu; Teruo Okano; Eiji Kobayashi; Takashi Daimon; Takayoshi Ueno; Toru Kuratani; Koichi Toda; Nobuyuki Takakura; Jun Hatazawa; Mikiyasu Shirai; Yoshiki Sawa
Journal:  Mol Ther       Date:  2014-11-25       Impact factor: 11.454

6.  A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.

Authors:  Jeffrey E Cohen; Brendan P Purcell; John W MacArthur; Anbin Mu; Yasuhiro Shudo; Jay B Patel; Christopher M Brusalis; Alen Trubelja; Alexander S Fairman; Bryan B Edwards; Mollie S Davis; George Hung; William Hiesinger; Pavan Atluri; Kenneth B Margulies; Jason A Burdick; Y Joseph Woo
Journal:  Circ Heart Fail       Date:  2014-06-05       Impact factor: 8.790

7.  Cell transplantation in heart failure: where do we stand in 2016?

Authors:  John W MacArthur; Andrew B Goldstone; Jeffrey E Cohen; William Hiesinger; Y Joseph Woo
Journal:  Eur J Cardiothorac Surg       Date:  2016-09       Impact factor: 4.191

8.  Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel.

Authors:  Ze-Wei Tao; Mohamed Mohamed; Matthew Hogan; Laura Gutierrez; Ravi K Birla
Journal:  J Tissue Eng Regen Med       Date:  2014-04-28       Impact factor: 3.963

9.  Fabrication of Thick and Anisotropic Cardiac Tissue on Nanofibrous Substrate for Repairing Infarcted Myocardium.

Authors:  Junjun Li; Li Liu; Itsunari Minami; Shigeru Miyagawa; Yoshiki Sawa
Journal:  Methods Mol Biol       Date:  2021

10.  Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.

Authors:  Hongran Wang; Yutao Xi; Yi Zheng; Xiaohong Wang; Austin J Cooney
Journal:  Stem Cell Res       Date:  2016-02-23       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.